Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionPhysicians Financial Services, Inc.
Latest Disclosed Ownership4,970 shares
Latest Disclosed Value $ 4,571
Physicians Financial Services, Inc. reports 21.28% increase in ownership of LLY / Eli Lilly and Company

On April 15, 2026 - Physicians Financial Services, Inc. filed a 13F-HR form disclosing ownership of 4,970 shares of Eli Lilly and Company (US:LLY) valued at $4,571,257 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 4,098 shares of Eli Lilly and Company. This represents a change in shares of 21.28% during the quarter. The current value of the position is $5,361,537 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F Eli Lilly COM 532457108 4,970 872 21.28 5 0.00 1.2515
2026-01-21 2025-12-31 13F Eli Lilly COM 532457108 4,098 102 2.55 4 33.33 1.1815
2025-10-21 2025-09-30 13F Eli Lilly COM 532457108 3,996 81 2.07 3 0.00 0.8323
2025-08-14 2025-06-30 13F Eli Lilly COM 532457108 3,915 308 8.54 3 50.00 0.9091
2025-05-07 2025-03-31 13F/A-1 Eli Lilly COM 532457108 3,607 570 18.77 3 0.00 0.9473
2025-05-07 2025-03-31 13F Eli Lilly COM 532457108 3,607 570 3 0.9473
2025-02-03 2024-12-31 13F Eli Lilly COM 532457108 3,037 8 0.26 2 0.00 0.7120
2024-10-31 2024-09-30 13F Eli Lilly COM 532457108 3,029 165 5.76 3 0.00 0.8347
2024-08-14 2024-06-30 13F Eli Lilly COM 532457108 2,864 51 1.81 3 0.00 0.8433
2024-05-10 2024-03-31 13F Eli Lilly COM 532457108 2,813 60 2.18 2 100.00 0.7704
2024-01-26 2023-12-31 13F Eli Lilly COM 532457108 2,753 25 0.92 2 0.00 0.6083
2023-10-31 2023-09-30 13F Eli Lilly COM 532457108 2,728 10 0.37 1 0.00 0.5994
2023-07-26 2023-06-30 13F Eli Lilly COM 532457108 2,718 50 1.87 1 0.5006
2023-05-17 2023-03-31 13F Eli Lilly COM 532457108 2,668 0 0.00 1 0.3873
2023-02-09 2022-12-31 13F Eli Lilly COM 532457108 2,668 0 0.00 1 -100.00 0.4395
2022-10-19 2022-09-30 13F Eli Lilly COM 532457108 2,668 0 0.00 863 -0.23 0.4171
2022-08-17 2022-06-30 13F Eli Lilly COM 532457108 2,668 0 0.00 865 13.22 0.3849
2022-04-22 2022-03-31 13F Eli Lilly COM 532457108 2,668 0 0.00 764 3.66 0.2917
2022-02-02 2021-12-31 13F Eli Lilly COM 532457108 2,668 0 0.00 737 19.64 0.2725
2021-10-27 2021-09-30 13F Eli Lilly COM 532457108 2,668 0 0.00 616 0.65 0.2495
2021-07-27 2021-06-30 13F Eli Lilly COM 532457108 2,668 -237 -8.16 612 12.71 0.2510
2021-05-21 2021-03-31 13F Lilly Eli COM 532457108 2,905 137 4.95 543 16.27 0.2327
2021-02-03 2020-12-31 13F Lilly Eli COM 532457108 2,768 0 0.00 467 13.90 0.2254
2020-11-10 2020-09-30 13F Lilly Eli COM 532457108 2,768 0 0.00 410 -9.69 0.2047
2020-07-28 2020-06-30 13F Eli Lilly COM 532457108 2,768 0 0.00 454 18.23 0.2509
2020-04-27 2020-03-31 13F Eli Lilly COM 532457108 2,768 0 0.00 384 5.49 0.2639
2020-02-12 2019-12-31 13F Eli Lilly COM 532457108 2,768 0 0.00 364 17.42 0.1969
2019-11-14 2019-09-30 13F Eli Lilly COM 532457108 2,768 0 0.00 310 0.98 0.1773
2019-08-12 2019-06-30 13F Eli Lilly COM 532457108 2,768 -270 -8.89 307 -22.08 0.1806
2019-04-12 2019-03-31 13F Eli Lilly COM 532457108 3,038 0 0.00 394 11.93 0.2449
2019-01-22 2018-12-31 13F Eli Lilly COM 532457108 3,038 3,038 352 0.2558
2017-04-26 2017-03-31 13F Lilly Eli COM 532457108 0 -1,738 -100.00 0 -100.00
2017-01-17 2016-12-31 13F Lilly Eli COM 532457108 1,738 0 0.00 145 4.32 0.1190
2016-11-01 2016-09-30 13F Lilly Eli COM 532457108 1,738 100 6.11 139 7.75 0.1159
2016-07-14 2016-06-30 13F Lilly Eli COM 532457108 1,638 165 11.20 129 21.70 0.1129
2016-04-26 2016-03-31 13F Lilly Eli COM 532457108 1,473 0 0.00 106 -14.52 0.0959
2016-02-09 2015-12-31 13F Lilly Eli COM 532457108 1,473 1,473 124 0.1145
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.